As the central cooperation platform for patient-oriented clinical research in Switzerland, the Swiss Clinical Trial Organisation (SCTO) is committed to high-quality and independent information and adhere to the overall principles of making clinical trial data transparent. Furthermore, we advocate for greater dialogue and collaboration between all parties involved. 

To this end, we pursue a range of activities, including:

• dedicating our annual event, the SCTO Forum 2021, to the topic of communicating clinical research results. COVID-19 will serve as an example for the major challenge of knowledge transfer from clinical research professionals to patients/the public and vice versa. How can we do better? A comprehensive public report will summarise the main takeaways from the discussions, and presentations can be listened to as a podcast afterwards.
• continuing to support swissethics in their information activities by providing feedback from our network and giving practical input on their guidance documents.

In addition, we regularly provide information about:

• Swiss participation in the international SOLIDARITY trial
• contributions made by our network, the Clinical Trial Units (CTUs) at Swiss hospitals.
• clinical research in Switzerland in general; for all media enquiries, please visit our media section.

Links:

• Joint Guidance of Swissmedic and swissethics on the management of clinical trials with medicinal drug products in Switzerland during the COVID-19 pandemic
• Our COVID-19 section Swiss participation in the international SOLIDARITY trial
• Our COVID-19 section How are the Clinical Trial Units in our network involved?

Show more

Hide

The COVID-19 crisis requires researchers to join forces worldwide to find a cure and a vaccine. The SCTO supports the coordination of ongoing projects as well as the pooling of resources. Sharing information, knowledge, and research data is a critical step in this global effort. Being part of the European Clinical Research Infrastructure Network (ECRIN) gives us access early on to such pertinent information.

Therefore, we regularly provide updates on the following:

• initiatives and projects at the international or European level, such as the new EU-funded research initiative called EU-RESPONSE and the European Medicines Agency’s (EMA) infrastructure to support the monitoring of the efficacy and safety of COVID-19 treatments and vaccines in daily clinical practice
• latest publications, guidelines, and recommendations at the international or European level through our online newsletter
• links and information about COVID-19 resources, such as ECRIN's Clinical Research Metadata Repository or COVID-evidence, a non-profit initiative of the Department of Clinical Research at University of Basel and the Meta-Research Innovation Center at Stanford with other international partners and collaborators.

Links:

• EU Commission provides information about EU-RESPONSE
• EMA sets up infrastructure for real-world monitoring of treatments and vaccines
• ECRIN's Clinical Research Metadata Repository
• COVID-evidence database
• Our COVID-19 section Overview of international COVID-19 initiatives and resources
• Registration form for the SCTO newsletter

Show more

Hide